Spots Global Cancer Trial Database for An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study
Official Title: An Open-label, Multicenter Extension Study of Onartuzumab in Patients With Solid Tumors on Study Treatment Previously Enrolled in an F.Hoffmann-la Roche- and/or Genentech- Sponsored Study
Study ID: NCT02488330
Conditions
Study Description
Brief Summary: This extension study will provide continued onartuzumab and/or parent trial (P-trial) designated control treatments to participants with cancer who were previously enrolled in a company-sponsored onartuzumab P-trial and who derived benefit, as assessed by the responsible investigator, from the therapy administered in the P-trial. The study will also collect safety data with regard to administration of continued onartuzumab therapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hopital Roger Salengro, Lille, , France
Azienda Ospedaliero Universitaria San Giovanni Battista Di Torino, Torino, Piemonte, Italy
National Hospital Organization Shikoku Cancer Center, Ehime, , Japan
Rigas Austrumu Kliniska Universitates slimnica, Latvijas Onkologijas centrs, Riga, , Latvia
Ivanovo Regional Oncology Dispensary, Ivanovo, , Russian Federation
Clin Hospital Center - Kragujevac; Pulmonary Diseases, Kragujevac, , Serbia
University of the Witwatersrand Research, Johannesburg, , South Africa
Sandton Oncology Medical Group, Sandton, , South Africa
Hospital Univ Vall d'Hebron; Servicio de Oncologia, Barcelona, , Spain
HOSPITAL DE MADRID NORTE SANCHINARRO- CENTRO INTEGRAL ONCOLOGICO CLARA CAMPAL; Servicio de Oncologia, Madrid, , Spain
Contact Details
Name: Clinical Trials
Affiliation: Hoffmann-La Roche
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
